Comparison of dual-echo DSC-MRI- and DCE-MRI-derived contrast agent kinetic parameters

Magnetic Resonance Imaging

Volumn 30, Issue 7, 2012, Pages 944-953

  Quarles, C Chad ^a,b,c   Gore, John C ^a,b,c   Xu, Lei ^a   Yankeelov, Thomas E ^a,b,c  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dynamic contrast enhanced; Dynamic susceptibility contrast; Perfusion; Permeability

Indexed keywords

GADOLINIUM PENTETATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFACT; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN TUMOR; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE MODEL; DRUG CLEARANCE; DRUG HALF LIFE; DYNAMIC CONTRAST ENHANCEMENT NUCLEAR MAGNETIC RESONANCE IMAGING; DYNAMIC SUSCEPTIBILITY CONTRAST NUCLEAR MAGNETIC RESONANCE IMAGING; EXTRACELLULAR SPACE; EXTRAVASCULAR SPACE; GLIOBLASTOMA; GLIOSARCOMA; INTERMETHOD COMPARISON; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOLOGICAL PARAMETERS; RAT; RELIABILITY; SIGNAL NOISE RATIO; SIGNAL PROCESSING; VOLUME FRACTION; VOLUME TRANSFER CONSTANT;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; COMPUTER SIMULATION; CONTRAST MEDIA; ECHO-PLANAR IMAGING; GADOLINIUM DTPA; GLIOSARCOMA; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; KINETICS; MALE; MODELS, BIOLOGICAL; RATS; RATS, INBRED F344; RATS, WISTAR; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

RATTUS;

EID: 84864001581     PISSN: 0730725X     EISSN: 18735894     Source Type: Journal    
DOI: 10.1016/j.mri.2012.03.008     Document Type: Article

References (41)

1. Yankeelov T.E., Gore J.C. Dynamic contrast enhanced magnetic resonance imaging in oncology. Curr Med Imaging Rev 2007, 3:91-107.
2. Ostergaard L. Principles of cerebral perfusion imaging by bolus tracking. J Magn Reson Imaging 2005, 22(6):710-717.
3. Tofts P., Kermode A. Measurement of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med 1991, 17:357-367.
4. Gossmann A., Helbich T.H., Kuriyama N., Ostrowitzki S., Roberts T.P., Shames D.M., van Bruggen N., Wendland M.F., Israel M.A., Brasch R.C. Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme. J Magn Reson Imaging 2002, 15(3):233-240.
5. Yankeelov T.E., Lepage M., Chakravarthy A., Broome E.E., Niermann K.J., Kelley M.C., Meszoely I., Mayer I.A., Herman C.R., McManus K., Price R.R., Gore J.C. Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. Magn Reson Imaging 2007, 25(1):1-13.
6. Aronen H.J., Cohen M.S., Belliveau J.W., Fordham J.A., Rosen B.R. Ultrafast imaging of brain tumors. Top Magn Reson Imaging 1993, 5(1):14-24.
7. Aronen H.J., Gazit I.E., Louis D.N., Buchbinder B.R., Pardo F.S., Weisskoff R.M., Harsh G.R., Cosgrove G.R., Halpern E.F., Hochberg F.H. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994, 191(1):41-51.
8. Delile J., Slanetz P., Yeh E., Kopans D., Garrido L. Breast cancer: regional blood flow and volume with magnetic susceptibility-based MR imaging. Radiology 2002, 223:558-565.
9. Muramoto S., Uematsu H., Sadato N., Tsuchida T., Matsuda T., Hatabu H., Yonekura Y., Itoh H. H(2) (15)0 positron emission tomography validation of semiquantitative prostate blood flow determined by double-echo dynamic MRI: a preliminary study. J Comput Assist Tomogr 2002, 26(4):510-514.
10. Donahue K.M., Krouwer H.G., Rand S.D., Pathak A.P., Marszalkowski C.S., Censky S.C., Prost R.W. Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients. Magn Reson Med 2000, 43(6):845-853.
11. Schmainda K.M., Rand S.D., Joseph A.M., Lund R., Ward B.D., Pathak A.P., Ulmer J.L., Badruddoja M.A., Krouwer H.G. Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis. AJNR Am J Neuroradiol 2004, 25(9):1524-1532.
12. Hakyemez B., Erdogan C., Ercan I., Ergin N., Uysal S., Atahan S. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. Clin Radiol 2005, 60(4):493-502.
13. Fuss M., Wenz F., Essig M., Muenter M., Debus J., Herman T.S., Wannenmacher M. Tumor angiogenesis of low-grade astrocytomas measured by dynamic susceptibility contrast-enhanced MRI (DSC-MRI) is predictive of local tumor control after radiation therapy. Int J Radiat Oncol Biol Phys 2001, 51(2):478-482.
14. Weber M.A., Thilmann C., Lichy M.P., Gunther M., Delorme S., Zuna I., Bongers A., Schad L.R., Debus J., Kauczor H.U., Essig M., Schlemmer H.P. Assessment of irradiated brain metastases by means of arterial spin-labeling and dynamic susceptibility-weighted contrast-enhanced perfusion MRI: initial results. Invest Radiol 2004, 39(5):277-287.
15. Lee M.C., Cha S., Chang S.M., Nelson S.J. Dynamic susceptibility contrast perfusion imaging of radiation effects in normal-appearing brain tissue: changes in the first-pass and recirculation phases. J Magn Reson Imaging 2005, 21(6):683-693.
16. Bruening R., Kwong K.K., Vevea M.J., Hochberg F.H., Cher L., Harsh G.R.T., Niemi P.T., Weisskoff R.M., Rosen B.R. Echo-planar MR determination of relative cerebral blood volume in human brain tumors: T1 versus T2 weighting. Am J Neuroradiol 1996, 17(5):831-840.
17. Quarles C.C., Ward B.D., Schmainda K.M. Improving the reliability of obtaining tumor hemodynamic parameters in the presence of contrast agent extravasation. Magn Reson Med 2005, 53(6):1307-1316.
18. Johnson G., Wetzel S.G., Cha S., Babb J., Tofts P.S. Measuring blood volume and vascular transfer constant from dynamic, T(2)*-weighted contrast-enhanced MRI. Magn Reson Med 2004, 51(5):961-968.
19. Colvin D.C., Yankeelov T.E., Does M.D., Yue Z., Quarles C., Gore J.C. New insights into tumor microstructure using temporal diffusion spectroscopy. Cancer Res 2008, 68(14):5941-5947.
20. Boxerman J.L., Schmainda K.M., Weisskoff R.M. Relative blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. Am J Neuroradiol 2006, 27:859-867.
21. Heiland S., Benner T., Debus J., Rempp K., Reith W., Sartor K. Simultaneous assessment of cerebral hemodynamics and contrast agent uptake in lesions with disrupted blood-brain-barrier. Magn Reson Imaging 1999, 17(1):21-27.
22. Vonken E.J., van Osch M.J., Bakker C.J., Viergever M.A. Measurement of cerebral perfusion with dual-echo multi-slice quantitative dynamic susceptibility contrast MRI. J Magn Reson Imaging 1999, 10(2):109-117.
23. Uematsu H., Maeda M., Sadato N., Matsuda T., Ishimori Y., Koshimoto Y., Kimura H., Yamada H., Kawamura Y., Yonekura Y., Itoh H. Blood volume of gliomas determined by double-echo dynamic perfusion-weighted MR imaging: a preliminary study. AJNR Am J Neuroradiol 2001, 22(10):1915-1919.
24. Sourbron S., Heilmann M., Biffar A., Walczak C., Vautier J., Volk A., Peller M. Bolus-tracking MRI with a simultaneous T1- and T2*-measurement. Magn Reson Med 2009, 62(3):672-681.
25. Bjornerud A., Sorensen A.G., Mouridsen K., Emblem K.E. T(1)- and T(2)(*)-dominant extravasation correction in DSC-MRI: Part I. Theoretical considerations and implications for assessment of tumor hemodynamic properties. J Cereb Blood Flow Metab 2011.
26. Buckley D.L. Transcytolemmal water exchange and its affect on the determination of contrast agent concentration in vivo. Magn Reson Med 2002, 47(2):420-424.
27. Yankeelov T.E., Rooney W.D., Li X., Springer C.S. Variation of the relaxographic "shutter-speed" for transcytolemmal water exchange affects the CR bolus-tracking curve shape. Magn Reson Med 2003, 50(6):1151-1169.
28. Quarles C.C., Gochberg D.F., Gore J.C., Yankeelov T.E. A theoretical framework to model DSC-MRI data acquired in the presence of contrast agent extravasation. Phys Med Biol 2009, 54(19):5749-5766.
29. Semmineh N.B., Xu J., Gore J.C., Quarles C.C. The assessment of tumor cellularity using DSC-MRI. Proceedings of the International Society of Magnetic Resonance in Medicine, Montreal, Canada 2011, 1084.
30. Kuperman V.Y., Karczmar G.S., Blomley M.J., Lewis M.Z., Lubich L.M., Lipton M.J. Differentiating between T1 and T2* changes caused by gadopentetate dimeglumine in the kidney by using a double-echo dynamic MR imaging sequence. J Magn Reson Imaging 1996, 6(5):764-768.
31. Vonken E.P., van Osch M.J., Bakker C.J., Viergever M.A. Simultaneous quantitative cerebral perfusion and Gd-DTPA extravasation measurement with dual-echo dynamic susceptibility contrast MRI. Magn Reson Med 2000, 43(6):820-827.
32. Barbier E.L., den Boer J.A., Peters A.R., Rozeboom A.R., Sau J., Bonmartin A. A model of the dual effect of gadopentetate dimeglumine on dynamic brain MR images. J Magn Reson Imaging 1999, 10(3):242-253.
33. d'Arcy J.A., Collins D.J., Rowland I.J., Padhani A.R., Leach M.O. Applications of sliding window reconstruction with cartesian sampling for dynamic contrast enhanced MRI. NMR Biomed 2002, 15(2):174-183.
34. Kim E.J., Kim D.H., Lee S.H., Huh Y.M., Song H.T., Suh J.S. Simultaneous acquisition of perfusion and permeability from corrected relaxation rates with dynamic susceptibility contrast dual gradient echo. Magn Reson Imaging 2004, 22(3):307-314.
35. Landis C.S., Li X., Telang F.W., Coderre J.A., Micca P.L., Rooney W.D., Latour L.L., Vetek G., Palyka I., Springer C.S. Determination of the MRI contrast agent concentration time course in vivo following bolus injection: effect of equilibrium transcytolemmal water exchange. Magn Reson Med 2000, 44(4):563-574.
36. Yankeelov T.E., Luci J.J., Lepage M., Li R., Debusk L., Lin P.C., Price R.R., Gore J.C. Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model. Magn Reson Imaging 2005, 23(4):519-529.
37. Cox R.W. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 1996, 29(3):162-173.
38. Yankeelov T.E., DeBusk L.M., Billheimer D.D., Luci J.J., Lin P.C., Price R.R., Gore J.C. Repeatability of a reference region model for analysis of murine DCE-MRI data at 7T. J Magn Reson Imaging 2006, 24(5):1140-1147.
39. Pathak A.P., Rand S.D., Schmainda K.M. The effect of brain tumor angiogenesis on the in vivo relationship between the gradient-echo relaxation rate change (DeltaR2*) and contrast agent (MION) dose. J Magn Reson Imaging 2003, 18(4):397-403.
40. Kiselev V.G. On the theoretical basis of perfusion measurements by dynamic susceptibility contrast MRI. Magn Reson Med 2001, 46(6):1113-1122.
41. Paulson E.S., Schmainda K.M. Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors. Radiology 2008, 249(2):601-613.